Summit Therapeutics Inc (SMMT)
4.41
+0.02
(+0.46%)
USD |
NASDAQ |
May 06, 09:57
Summit Therapeutics Price to Book Value: 70.02 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 69.71 |
| May 02, 2024 | 64.47 |
| May 01, 2024 | 74.63 |
| April 30, 2024 | 62.40 |
| April 29, 2024 | 61.61 |
| April 26, 2024 | 61.29 |
| April 25, 2024 | 56.37 |
| April 24, 2024 | 57.00 |
| April 23, 2024 | 59.23 |
| April 22, 2024 | 55.42 |
| April 19, 2024 | 55.57 |
| April 18, 2024 | 55.73 |
| April 17, 2024 | 56.69 |
| April 16, 2024 | 56.21 |
| April 15, 2024 | 58.03 |
| April 12, 2024 | 58.19 |
| April 11, 2024 | 63.99 |
| April 10, 2024 | 63.51 |
| April 09, 2024 | 64.78 |
| April 08, 2024 | 62.72 |
| April 05, 2024 | 61.61 |
| April 04, 2024 | 56.21 |
| April 03, 2024 | 62.72 |
| April 02, 2024 | 61.13 |
| April 01, 2024 | 63.20 |
| Date | Value |
|---|---|
| March 28, 2024 | 37.39 |
| March 27, 2024 | 33.87 |
| March 26, 2024 | 33.78 |
| March 25, 2024 | 29.62 |
| March 22, 2024 | 30.44 |
| March 21, 2024 | 32.06 |
| March 20, 2024 | 34.59 |
| March 19, 2024 | 32.79 |
| March 18, 2024 | 37.17 |
| March 15, 2024 | 41.73 |
| March 14, 2024 | 42.90 |
| March 13, 2024 | 40.73 |
| March 12, 2024 | 38.93 |
| March 11, 2024 | 38.84 |
| March 08, 2024 | 39.74 |
| March 07, 2024 | 42.63 |
| March 06, 2024 | 43.71 |
| March 05, 2024 | 45.79 |
| March 04, 2024 | 40.46 |
| March 01, 2024 | 42.00 |
| February 29, 2024 | 41.00 |
| February 28, 2024 | 40.91 |
| February 27, 2024 | 39.74 |
| February 26, 2024 | 40.28 |
| February 23, 2024 | 41.91 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7965
Minimum
Jun 14 2019
74.63
Maximum
May 01 2024
8.077
Average
4.879
Median
Price to Book Value Benchmarks
| Retractable Technologies Inc | 0.3324 |
| BioCardia Inc | -- |
| Alpine Immune Sciences Inc | 12.91 |
| Axsome Therapeutics Inc | 19.10 |
| Krystal Biotech Inc | 5.549 |
Price to Book Value Related Metrics
| PS Ratio | 3227.57 |
| Price | 4.41 |
| Earnings Yield | -2.72% |
| Market Cap | 3.096B |